« BackJournal of Critical Care
Article in Press

Evolution of neutrophil apoptosis in septic shock survivors and nonsurvivors☆☆

  • Eduardo Tamayo, MD, PhD

      Affiliations

    • Department of Anaesthesiology and Intensive Care, Hospital Clínico Universitario de Valladolid, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Esther Gómez, MD, PhD

      Affiliations

    • Department of Anaesthesiology and Intensive Care, Hospital Clínico Universitario de Valladolid, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Juan Bustamante, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery. Hospital Universitario La Princesa, 28006 Madrid, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 915202268; fax: +34 915202201.
    • Valladolid Sepsis Study Group.
  • ,
  • José I. Gómez-Herreras, MD, PhD

      Affiliations

    • Department of Anaesthesiology and Intensive Care, Hospital Universitario Rio Hortega, 47012 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Rosalba Fonteriz, MD, PhD

      Affiliations

    • Institute of Biology and Molecular Genetics (IBGM/CSIC), Universidad de Valladolid, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Felipe Bobillo, MD, PhD

      Affiliations

    • Medical Intensive Care Unit, Hospital Clínico Universitario de Valladolid, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Jesús F. Bermejo-Martín, MD, PhD

      Affiliations

    • Infection & Immunity Unit, Hospital Clinico Universitario de Valladolid -IECSCYL, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Javier Castrodeza, MD, PhD

      Affiliations

    • Direction of Public Health, Investigation, Development and Innovation, SACYL, 47007 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Maria Heredia, MD

      Affiliations

    • Department of Anaesthesiology and Intensive Care, Hospital Clínico Universitario de Valladolid, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Inma Fierro, MD

      Affiliations

    • Department of Pharmacology and Therapeutics, Facultad de Medicina, Universidad de Valladolid, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.
  • ,
  • Francisco Javier Álvarez, MD, PhD

      Affiliations

    • Department of Pharmacology and Therapeutics, Facultad de Medicina, Universidad de Valladolid, 47005 Valladolid, Spain
    • Valladolid Sepsis Study Group.

published online 14 November 2011.
Corrected Proof

Abstract 

Purpose

The aims were to analyze the temporal evolution of neutrophil apoptosis, to determine the differences in neutrophil apoptosis among 28-day survivors and nonsurvivors, and to evaluate the use of neutrophil apoptosis as a predictor of mortality in patients with septic shock.

Materials and Methods

Prospective multicenter observational study carried out between July 2006 and June 2009. The staining solution study included 80 patients with septic shock and 25 healthy volunteers. Neutrophil apoptosis was assessed by fluorescein isothiocyanate (FITC)–conjugated annexin V and aminoactinomycin D staining.

Results

The percentage of neutrophil apoptosis was significantly decreased at 24 hours, 5 days, and 12 days after the diagnosis of septic shock (14.8% ± 13.4%, 13.4% ± 8.4%, and 15.4% ± 12.8%, respectively; P < .0001) compared with the control group (37.6% ± 12.8%). The difference in apoptosis between 28-day surviving and nonsurviving patients was nonsignificant (P > .05). The mortality rate at 28 days was 53.7%. The crude hazard ratio for mortality in patients with septic shock did not differ according to the percentage of apoptosis (hazard ratio, 1.006; 95% confidence interval, 0.98-1.03; P = .60).

Conclusions

During the first 12 days of septic shock development, the level of neutrophil apoptosis decreases and does not recover normal values. No differences were observed between surviving and nonsurviving patients.

Keywords: Apoptosis, Neutrophil, Septic shock, Mortality, Survivors

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of Interest: None declared.

☆☆ Funding Sources: This work was supported in part by a grant from the “Gerencia de Salud, Consejería de Sanidad, Junta de Castilla y Leon” (GRS 143/ A/07) and Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional FEDER, Red de Trastornos Adictivos RD06/0001/0020.

PII: S0883-9441(11)00433-3

doi:10.1016/j.jcrc.2011.09.001

« BackJournal of Critical Care